We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

174 hedge funds and large institutions have $105M invested in Definium Therapeutics in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 17

59% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 34

18% more call options, than puts

Call options by funds: $7.82M | Put options by funds: $6.62M

12% more funds holding

Funds holding: 155 → 174 (+19)

0.13% more ownership

Funds ownership: 0.74% → 0.87% (+0.13%)

20% less capital invested

Capital invested by funds: $130M → $105M (-$25.5M)

Holders
174
Holders Change
+19
Holders Change %
+12.26%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
54
Reduced
34
Closed
17
Calls
$7.82M
Puts
$6.62M
Net Calls
+$1.21M
Net Calls Change
-$1.76M

Top Buyers

1
Northern Trust
Northern Trust
Illinois
+$6.83M
2
State Street
State Street
Massachusetts
+$3.34M
3
BlackRock
BlackRock
New York
+$2.87M
4
BB
Busey Bank
Illinois
+$2.35M
5
Goldman Sachs
Goldman Sachs
New York
+$2.14M

Top Sellers

1
Jane Street
Jane Street
New York
-$1.65M
2
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$737K
3
UBS AM
UBS AM
Illinois
-$567K
4
VF
Virtu Financial
New York
-$564K
5
JP Morgan Chase
JP Morgan Chase
New York
-$532K
Name Holding Trade Value Shares
Change 		Change in
Stake
IWM
76
IHT Wealth Management
Illinois
$70K – – –
APA
77
American Portfolios Advisors
New York
$69.9K – – –
SAM
78
Shell Asset Management
Netherlands
$69K -$3.46K -80 -4%
T. Rowe Price Associates
79
T. Rowe Price Associates
Maryland
$67K +$2.85K +66 +4%
Wolverine Trading
80
Wolverine Trading
Illinois
$64K -$150K -3,465 -65%
PAMS
81
Pictet Asset Management (Switzerland)
Switzerland
$64K +$79.2K +1,831 New
AWM
82
Accurate Wealth Management
Florida
$63K +$11.2K +260 +17%
Wells Fargo
83
Wells Fargo
California
$61K +$74K +1,712 +5,035%
AIP
84
Ameritas Investment Partners
Nebraska
$59K – – –
CCA
85
Conservest Capital Advisors
Pennsylvania
$55K – – –
Prudential Financial
86
Prudential Financial
New Jersey
$53K +$3.2K +74 +5%
KJHP
87
K.J. Harrison & Partners
Ontario, Canada
$52K – – –
WS
88
Wedbush Securities
California
$52K +$64.8K +1,500 New
EP
89
Eudaimonia Partners
Tennessee
$47K +$14.4K +333 +33%
Mackenzie Financial
90
Mackenzie Financial
Ontario, Canada
$45K +$54.5K +1,261 New
TYCC
91
Texas Yale Capital Corp
Florida
$40K – – –
FDCDDQ
92
Federation des caisses Desjardins du Quebec
Quebec, Canada
$38.7K -$1.73K -40 -3%
SBF
93
Sara-Bay Financial
Florida
$38K -$8.65K -200 -16%
X
94
Xponance
Pennsylvania
$38K -$3.63K -84 -7%
I
95
INVST
Indiana
$37K – – –
CAM
96
Close Asset Management
United Kingdom
$37K +$46.1K +1,067 New
CIBC World Market
97
CIBC World Market
Ontario, Canada
$36K +$44.3K +1,025 New
PTP
98
Platform Technology Partners
New York
$35K – – –
V
99
Veritable
Delaware
$35K – – –
UCFA
100
United Capital Financial Advisors
Texas
$35K +$43.4K +1,005 New
2 3
4
5 6

DFTX Hedge Fund Activity: Q3 2021 in Review

174 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2021, worth a combined $105M — down 20% from $130M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new DFTX positions and 17 closed out — a net gain of 22 holders — while 54 added to existing stakes and 34 trimmed.

The largest buyer was Northern Trust, adding an estimated $6.83M. The largest seller was Jane Street, cutting an estimated $1.65M.

  • 174 institutional investors held Definium Therapeutics (DFTX) as of Q3 2021, up from 155 in Q2 2021.
  • Funds reported $105M of Definium Therapeutics stock for Q3 2021, down 20% quarter-over-quarter.
  • 39 funds opened new Definium Therapeutics positions in Q3 2021 and 17 closed out, a net change of +22 holders.
  • The largest Definium Therapeutics buyer in Q3 2021 was Northern Trust, an estimated $6.83M added.
  • The largest Definium Therapeutics seller in Q3 2021 was Jane Street, an estimated $1.65M sold.

Based on aggregated 13F filings for Q3 2021.